International hypoxia symposium XVIII: 26 February–02 March 2013 by unknown
Pun and Basnyat Extreme Physiology & Medicine 2013, 2:32
http://www.extremephysiolmed.com/content/2/1/32MEETING REPORT Open AccessInternational hypoxia symposium XVIII:
26 February–02 March 2013
Matiram Pun1,2* and Buddha Basnyat1,3,4,5Abstract
The 18th International Hypoxia Symposia, Lake Louise, Alberta, Canada, February 26–March 02, 2013, covered
molecular basis of hypoxic responses (e.g., hypoxia inducible factor, nitrite, nitrate, and hemoglobin) and integrative
physiology (e.g., exercise physiology, cerebral blood flow responses, live-high train-low, and population genetics).
Free communications and poster sessions covered scientific areas from controlled lab settings to field settings of
high altitudes (Andes to Himalayas).
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Hypoxia is an inadequate supply of oxygen to our body
which could be generalized (to a whole body) or localized
(in a particular tissue). Although slight variation of arterial
oxygen concentration in human tissue can be a normal
physiology, a significant desaturation for a longer period of
time (hypoxia) is a pathological conditi on. Hypoxia occurs
in many varied settings, e.g., intensive care units, stroke
units, in sleep-disordered breathing, high-altitude excur-
sions, and in cancer tissues. Hypoxia poses a significant
threat to the human body and vital organs throughout life.
Hence, better understanding of hypoxia pathophysiology is
important in various disease management to achieve better
outcome. The International Hypoxia Symposia that takes
place every 2 years has been a specialized but extremely vi-
brant conference in the field of hypoxia.
Currently, it is organized by Dr. Robert Roach and Dr.
Peter Hackett (both from CO, USA). It was started in 1973
in its earlier form by Dr. Charles Houston. The credit for
founding this present day symposia goes to Charles Hous-
ton, Geoff Coates and John Sutton. Their vision behind this
symposium was to facilitate scientists, clinicians, mountain-
eers and other interested individuals to share their experi-
ences on lack of oxygen in various settings. The Charlie
Houston legacy has been maintained, and the quality of sci-
ence is excellent. Since 2005, it has always been held at the* Correspondence: matiram@gmail.com
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2013Chateau at the picturesque Lake Louise in the heart of
Banff National Park in the Canadian Rockies during the
week of the full moon (February–March of the year).
Hypoxia XVIII: 2013
The 18th International Hypoxia Symposia started on the
evening of the 26th of February, 2013 at Lake Louise,
Alberta, Canada inside the luxurious Chateau Lake Louise
with a welcome reception. The scientific program on the
following days was very exciting with a great mixture of la-
boratory and field studies.
27 February, Wednesday
The first session in the morning was on chronic inter-
mittent hypoxia (CIH), the hallmark of sleep-disordered
breathing especially obstructive sleep apnea, and its effect
on cardiorespiratory system. The leaders in the field
Dr. Nanduri Prabhakar (University of Chicago, Chicago, IL,
USA), Dr. Gregg L Semenza and Dr. Larissa Shimoda (both
from Johns Hopkins University School of Medicine,
Baltimore, MD, USA) covered the topic in great depth. The
primary focus was CIH-triggered transcriptional factors,
e.g., hypoxia inducible factors (HIF1α and HIF2α), reactive
oxygen species (ROS) and their perturbations in cardiore-
spiratory homeostasis. While controlled experiments with
intermittent hypoxia (IH) have promising results to under-
stand physiological effects, they do not exactly reflect what
real human patients, e.g., obstructive sleep apnea (OSA),
suffer from especially in terms hypercapnia. The expe-
rimental limitations were aptly raised by The experimental
limitations were aptly raised by Dr. Barbara Morgantral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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and Dr. Prabhakar highlighted the challenges of titrating
carbon dioxide in experimental animals. It highlights the
need of experimental preparation that addresses true dis-
ease picture in human. After coffee break, Dr. Jose Calbet
(University of Las Palmas de Gram Canaria, Spain) pre-
sented invasive and non-invasive experimental setups in
humans to tease out the role of oxygenation (both partial
pressure and blood oxygen saturation) during maximal ex-
ercise. These sophisticated and invasive experiments are
important in understanding human and integrative physi-
ology, but there were few aspects, e.g., role of carbon mon-
oxide in vascular level, that were not adequately elucidated
as raised by Dr. Mark Gladwin (University of Pittsburgh,
Pittsburgh, PA, USA). Dr. Tatum Simonson (University of
California at San Diego, La Jolla, CA, USA) discussed the
genetic basis of high-altitude adaptation especially concen-
trating on a number of publications which emerged in
2010–2012, verifying (genetically) the early observations by
Dr. Cynthia Beall from Case Western Reserve University,
Cleveland, Ohio, USA (normal range of hemoglobin level
among well-adapted Sherpas, Tibetans, and Andeas). Al-
though there is remarkable progress and there are a num-
ber of publications in this field, the momentum in search of
genetic basis of high adaptation seems slowed down. There
are few other aspects, i.e., other markers of adaptations,
since it is less likely that they are the only aspects. There
has not been much work on the different mechanisms of
adaptations between Tibetan vs Andean high-altitude
dwellers. Similarly, there are other highlanders from
Ethiopia and Kyrgyzstan. We do not know if there are dif-
ferent genetic basis of high adaptations among these
groups. The final speaker of the session, Dr. Gladwin
(Pittsburgh), discussed the biochemical pathways of nitric
oxide (NO) and its intravascular oxidation which subse-
quently converted it into an anion nitrite which he won-
derfully described how it contributes in physiological
vasodilation, blood pressure regulation, and cellular re-
sponses to stresses like hypoxia and ischemia. The speaker
dissected the physiological roles of NO (along with nitrite
anion) in vascular and mucosal beds. The experiments
and data looked promising for application in clinical trials.
The poster session (I) that day had a number of
topics which spanned from ventilatory responses to
hypoxia both in animals and humans (Dr. Barbara
Morgan, Dr. Jean-Paul Richalet, Dr. Ri-Li Ge, Dr.
Marc J Poulin), chemosensitivity to hypoxia in COPDs
Dr. Michael K Stickland, Dr. Craig D Steinback), and
to high-altitude field studies (from the Himalayas and
the Andes) including genetic studies. The Himalayan
expedition lead by Dr. Philip N Ainslie (University of
British Columbia Okanagan, Kelowna, BC, Canada)
and the Andean expedition lead by Dr. Robert Roach
(University of Colorado School of Medicine, Aurora,CO, USA) presented interesting physiological experi-
ments from the high-altitude field.
In the evening, Dr. Steve Herrero (University of Calgary,
Calgary, AB, Canada) provided an intriguing insight into
the life and habitat of bears from the Canadian Rockies.
Dr. Herrero who has devoted his life in studying bears
highlighted the long and enduring effort of male bears to
convince females for mating.
28 February, Thursday
The morning session started with Tibetan physiology by
Dr. Peter Robbins (University of Oxford, Oxford, UK) who
provided an overview of the Tibetan plateau, hypoxia, and
inhabitation referring to genomic insights that came out in
2010–2011 which highlighted the adaptive responses to
high-altitude hypoxia especially the HIF pathway. He effect-
ively correlated the hypo-responsive HIF pathway to limit
excessive red blood cell production, leading to polycy-
themia. Then, there were some aspects with current
globalization and movement, i.e., some of the experimental
data among Tibetans who have been living at sea level for a
while. The genetic basis of these migrated Tibetans is prob-
ably maintained, but the physiological parameters will have
to be carefully interpreted since many of them most likely
have already spent decades in lowland before they were
assessed in Dr. Robbins' physiology lab. Dr. Josef Prchal
(University of Utah, Salt Lake City, UT, USA) discussed the
hematological aspects of hypoxia-induced transcriptional
factors (both up- and down-regulating). Congenital defects
and Chuvash polycythemia seem to be perfect examples of
hypoxia-sensing mechanism resulting in polycythemia.
Dr. Don McClain (University of Utah, Salt Lake City, UT,
USA) covered the metabolic adaptation to high attitude. It
seems that the adaptation mechanism has led to relative
‘metabolic inflexibility’, i.e., the narrow range in the ability
to shift between glucose and fatty acid oxidation. The car-
diovascular and hematological parameters are no doubt im-
portant aspects of physiological basis of high-altitude
adaptation. But at the same time, the data could be useful
in understanding other chronic lowland diseases, e.g.,
Chuvashia polycythemia. After coffee break, ‘The Exercising
Hypoxic Brain’ theme began, and Dr. Peter Rasmussen
(University of Copenhagen, Copenhagen, Denmark) dis-
cussed about exercise-induced hypocapnia leading to de-
creased cerebral blood flow (CBF) based on the hypothesis
that fatigue might be from the central command. Dr. Albert
Gjedde (University of Copenhagen, Copenhagen, Denmark)
discussed about metabolic demands of the brain and the
roles played by glia and neuronal synapses. The final
speaker of the session, Dr. Han van Lieshout (Amsterdam
Medical Center, Amsterdam, The Netherlands), described
the different mechanisms (cardiac diseases, arrhythmias,
and orthostatic hypotensions) of syncope and especially
about transient global cerebral hypoperfusion relating to
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ice-water immersion, and intense exercise. The session was
more of human integrative physiology and primarily fo-
cused on exercise physiology. While exercise physiology re-
mains at the center of integrative physiology, it is
mandatory that conferences like this should include
broader aspects of integrative physiology in the future.
After ski break, the hot topic session (Hot Topics in
Hypoxia I) started with the science of looking for key
facts about high-altitude adaptation and physiological
acclimatization. The roles of nitric oxide and structural
features of microcapillary (Dr. Beall) seem important.
However, there were quite a large individual variability
in the length and tortuosity of microcapillaries. At the
same time, the analyses of video images for capillaries
were taken from the clearest section of multiple frames
and length of videos. Erythropoetin seems to regulate
ventilatory responses in a gender-dependent manner
(females), while the familiar drug acetazolamide remains
a robust tool to explore hypoxic pathophysiology, e.g.,
cerebral oxygen metabolism (CMRO2, Dr. David Dubowitz
from University of California at San Diego, San Diego,
CA, USA) and central sleep apnea Dr. Keith R Burgess
(University of Sydney, Sydney, Australia), with interesting
results. The high-dose intravenous infusion of acetazol-
amide by Dr. Burgess et al. at high altitude to study sleep
and brain blood flow was carefully taken by Dr. Luc J.
Teppema (Leiden University Medical Centre, Leiden,
The Netherlands) and Dr. Jerome Dempsey (University
of Wisconsin-Madison, Madison, WI, USA), but the phy-
siological variables and results were quite remarkable
in this study. The role of dobutamine (along with
acetazolamide) infusion in this study on measured physio-
logical parameters was not adequately highlighted. Studies
from the high-altitude field expeditions with invasive
techniques and other modern methods continue to explore
exercise limitation, brain blood flow, and substrate metabol-
ism (Dr. Ainslie), as well as controlled invasive laboratory
studies to explore susceptibilities to acute high-altitude
illnesses (Dr. Michael Koehle from Univesity of British
Columbia, Vancouver, BC, Canada). Again, it was clear
that the hunt for new markers (S-adenosylmethionine
decarboxylase 1) of hypoxic vascular response continues
(Dr. Norbert Weissmann from Universities of Giessen and
Marburg Lung Centre, Giessen, Germany), while more
mechanistic studies keep exploring key cardiopulmonary
features of acclimatization (Dr. Glen E Foster from
University of British Columbia Okanagan, Kelowna, BC,
Canada; Dr. Andrew Lovering from University of Oregon,
Eugene, OR, USA and Dr. Ainslie).
In the evening, Bernadette McDonald, writer and moun-
tain culture consultant (Banff, Canada), gave a fascinating
talk on the lives and climbing achievements of Polish
climbers in the Himalayas during the communist regime.The post-Second World War economic crisis, skeptic
communist regime, and mountaineering had tremendous
effect on the life, family, and subsistence of these tough
Polish climbers, many of them ended up dying up in the
mountains.
01 March 2013, Friday
The first session theme ‘Cerebral Blood Flow in Hypoxia:
From Early Human Experiments to New Discoveries’
started with Dr. John Severinghaus (University of Califor-
nia, San Francisco, CA, USA) highlighting historical per-
spective of CBF measurements under hypoxic exposure
and ventilatory response. He discussed the role of cerebral
spinal fluid pH (logarithm of the reciprocal of hydrogen
ion concentration) buffering, CBF during hypoxic hypocap-
nia, and later experiments clamping CO2. Dr. Severinghaus
provided a detailed account of early high-altitude studies
by a team of anesthesiologists doing spinal fluid analysis
and infusion studies. This was followed by Dr. Ainslie
(UBC, Okanagan) who concluded that initial increase of
CBF is not the risk factor of acute mountain sickness
(AMS) (ideally, increased CBF should lead to increased ICP
and be the predictor of AMS). Dr. Ainslie elegantly
highlighted the mechanism of CBF, although autoregula-
tion aspect was not covered. Then, Dr. Andrew Subudhi
(University of Colorado School of Medicine, Aurora, CO,
USA) discussed about the limitations of the current tech-
niques of measuring CBF. Dr. Subudhi highlighted that
other aspects of blood flow measurements to the brain
could be equally important especially carotid and vertebral
artery blood flow measurements while we try to under-
stand brain from blood flow point of view. After coffee
break, a pro-con session on ‘Is Live-High Train-Low
(LHTL) Effective for Improving Sea Level Athletic Perform-
ance?’ started with Dr. Benjamin Levine (University of
Texas Southwestern Medical Center, Dallas, TX, USA) on
the affirmative side and Dr. Carsten Lundby (University of
Zurich, Zurich, Switzerland) on the opposition side. Dr.
Levine showed elegantly how it works, while Dr. Lundby
presented randomized trial data as well as meta-analysis
against this concept. Dr. Dempsey (Wisconsin-Madison)
and Dr. Poulin (University of Calgary, Calgary, AB, Canada)
were moderating the session. Dr. Dempsey presented neu-
tral views from the chair's perspective, basically highlight-
ing how intermittent hypoxia exposure (with reference to
obstructive sleep apnea and healthy human models of it)
affects cardiovascular system. In the end, both Dr. Levine
and Dr. Lundby agreed that the LHTL is a case-by-case
situation and depends upon individual response. Over
the period of discussion, it seemed that we were quite
mixed up with continuous hypoxia vs intermittent
hypoxia as well as normobaric hypoxia vs hypobaric
hypoxia. Future studies will have to meticulously tease
out these different modalities of physiological stimuli
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adaptation and maladaptation).
After ski break, poster session (II) was presented,
where the topics spanned widely from indoor pollution
(Dr. Analisa Cogo from University of Ferrara, Ferrara,
Italy) to vascular transcriptional factors from high-altitude
pulmonary edema patients (Dr. Ri-Li Ge from Qinghai
University Medical College, Xining, Qinghai, China), and
from hypoxia and field studies in human, exploring key
physiological responses to hypoxia during acclimatization
from different established research groups (Dr. Ainslie,
Dr. Roach, and Dr. Jim L. Rupert from Univesity of British
Columbia, Vancouver, BC, Canada). Similarly, the posters
on ventilation, vascular responses, and molecular basis
were presented from controlled experiments in humans
(Dr. Poulin from Calgary, Dr. Dubowitz from San Diego,
Dr. Patrick Levy from Hypoxia Pathophysiology Labora-
tory, INSERM, Grenoble, France and Dr. Lars I Erikson
from Karolinska Institute, Stockholm, Sweden). The sci-
ence presented was largely molecular with modern devel-
opment of technology.
In the evening, Dr. Tom Hornbein (University of
Washington School of Medicine, Seattle, Washington,
USA) talked about his audacious venture in succeeding
to climb Mt. Everest. He captivated us all with his pres-
entation. The audience provided a standing ovation for
his remarkable adventure, contribution to science, and
for this wonderful evening session.
02 March 2013, February
Dr. Gladwin (Pittsburg) opened the session with intricate
details of nitric oxide pathways (nitrate to nitrite to NO)
with recent discoveries in the field challenging traditional
dogma. The pathophysiological significance and signaling
pathways of nitric oxide in different systems and orga-
nelles were provided. The field seems very interesting and
may lead a number of clinical trials in coming years espe-
cially when it looks promising in patient management.
However, an important caveat that still remains unclear is
the mode of drug delivery. If oral ingestion is as effective
as thought, it will be interesting to see the results.
Dr. Andrew Jones (University of Exeter, Exeter, UK)
presented about dietary nitrate supplementation on
skeletal muscle oxygenation and energetics from
normoxia-hypoxia exercise trials. The calibrated 31P-MRS
and T2 weighted MRI data showed that the dietary sup-
plementation (beetroot juice rich in nitrate) improves
muscle energetics, functional capacity, and faster recov-
ery during exercise in hypoxia. It was a robust science
and an excellent presentation. The award winning pres-
entation from Dr. Jones was very well appreciated in the
conference partly because beetroot is inexpensive and
can be consumed as a dietary supplement. The trials
conducted by Dr. Jones were interesting especially whenthe subjects were well controlled with nitrate-depleted
beetroot juice. It really seems a promising field, and fur-
ther studies from different discipline are expected in the
future.
The final session Dr. Michael Joyner (Mayo Clinic,
Rochester, MN, USA) covered exercise-induced vaso-
dilation during hypoxia, normoxia, and hyperoxia along
with perfusion pressure. Dr. Joyner started his presenta-
tion by highlighting how integrative physiology helped
reduce patient morbidity and mortality from periopera-
tive to postoperative phases especially due to anesthetic
complications. The involvement of α-adrenergic and
β-adrenergic mechanisms along with nitric oxide (and
also the interaction among them) involved in vascular per-
fusion during exercise (normoxia, hypoxia, and hyperoxia)
were discussed. The human integrative physiology was
aptly highlighted.
After coffee break, Dr. Mary Slingo (University of
Oxford, Oxford, UK) discussed very clearly but in great
detail cellular mechanism of hypoxia sensing from ani-
mal models of Chuvash polycythemia and correlated
them with the findings from human patients. Dr. Slingo
did an excellent job in bringing molecular biology (wet
lab bench to be integrated in human physiology and pa-
tients with Chuvashia model). The last speaker, Dr. Peter
Ratcliffe (University of Oxford, Oxford, UK), discussed the
overall cellular mechanisms responsible for hypoxia and
stress. The genetic basis of hypoxic stress and its physio-
logical responses were summarized. Most importantly,
Dr. Ratcliffe pointed out that not all molecular/genetic
pathways are translated into physiological responses,
which highlights the importance of integrative physi-
ology. It is important to note that the reductionism
approach is not the ultimate of all physiological re-
searches, but rather it is integrative.
After ski break, the hot topics in hypoxia (Hot Topics
in Hypoxia II) covered a great mixture of human studies
(Dr. Bengt Keyser from University of Geneva, Geneva,
Switzerland; Dr. Konrad E Bloch and Dr. Marco Maggiorini
from University Hospital of Zurich, Zurich, Switzerland;
Dr. Ri-Li Ge; Dr. Justin Lawley from Bangor University,
Bangor, Gwynedd, UK) and animal (culture) studies
along with acute hypoxia to chronic hypoxia (Dr. Jeff
F Dunn from University of Calgary, Calgary, AB,
Alberta; Dr. Graham Scott from McMaster University,
Hamilton, ON, Canada and Dr. Omolara Ogunshola
from (University of Zurich, Zurich, Switzerland). The
human studies were mainly from the high-altitude
fields and had attempted to study disease pathophysi-
ology. At the same time, the laboratory studies were
much more mechanistic, trying to understand basic
mechanisms.
Finally, in the evening, there was a sumptuous dinner
with award presentations and dance to live music.
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